Reason for request
Inclusion on the list of medicines refundable by National Health Insurance and approved for hospital use.
Clinical Benefit
| Low |
The actual benefit of BRONCHITOL is low. |
Clinical Added Value
| no clinical added value |
BRONCHITOL does not offer any improvement in actual benefit (IAB V) in the management of adult patients aged 18 and over with cystic fibrosis. |
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
kjeADgYFjZnMdjB7
Listen
